Journals / art / 2018 / Cilt: 33 - Sayı: 2

Evaluation of Impact of Interferon-Induced Helicase C Domain-Containing Protein 1 Gene in Egyptian Systemic Lupus Erythematosus Patients and its Relationship With Vascular Manifestations of the Disease

Journal
art
Pages
181–189
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Expression of IFIH1 gene is related to disease activity and may serve as a novel predictor of vascular affection in SLE.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to investigate the impact of interferon-induced helicase C domain-containing protein 1 (IFIH1) gene single nucleotide polymorphism (SNP) on interferon pathway signaling in systemic lupus erythematosus (SLE) patients specifically with vascular affection.
📊
Key Findings & Data:Patients and methods: The cross-sectional study included 30 consecutive SLE patients (2 males, 28 females; mean age 28±3.4 years; range, 16 to 40 years) diagnosed according to the American College of Rheumatology revised criteria and 10 healthy age- and sex-matched controls (2 males, 8 females; mean age 27±2.5 years; range 22 to 23 years).
💡
Conclusion & Impact:Expression of IFIH1 gene is related to disease activity and may serve as a novel predictor of vascular affection in SLE.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: This study aims to investigate the impact of interferon-induced helicase C domain-containing protein 1 (IFIH1) gene single nucleotide polymorphism (SNP) on interferon pathway signaling in systemic lupus erythematosus (SLE) patients specifically with vascular affection. Patients and methods: The cross-sectional study included 30 consecutive SLE patients (2 males, 28 females; mean age 28±3.4 years; range, 16 to 40 years) diagnosed according to the American College of Rheumatology revised criteria and 10 healthy age- and sex-matched controls (2 males, 8 females; mean age 27±2.5 years; range 22 to 23 years). SLE patients and controls were compared in terms of quantitative reverse transcriptase polymerase chain reaction gene expression of IFIH1 gene, von Willebrand factor, carotid intima-media thickness, and Ankle Brachial Index. Results: Interferon-induced helicase C domain-containing protein 1 gene expression was significantly higher in SLE patients than controls (1.7±0.6 and 0.5±0.2, respectively) (p<0.0001). IFIH1 gene expression was highly related to vascular complication with a cutoff point at 1.74 and it positively correlated with other endothelial dysfunction markers. Conclusion: Interferon-induced helicase C domain-containing protein 1 gene (SNP 1990670) is associated with SLE in Egyptian patients. Expression of IFIH1 gene is related to disease activity and may serve as a novel predictor of vascular affection in SLE.

🔖

Cite This Article

NASSEF, S., ESSAM, M., ABDELFATTAH, D., ELSEHEMY, D., ABOUELEZZ, S. (2018). Evaluation of Impact of Interferon-Induced Helicase C Domain-Containing Protein 1 Gene in Egyptian Systemic Lupus Erythematosus Patients and its Relationship With Vascular Manifestations of the Disease. art, Cilt: 33 - Sayı: 2, 181–189. https://ajindex.com/articles/158940

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Wilhelm AJ, Major AS. Accelerated atherosclerosis in SLE: mechanisms and prevention approaches. Int J Clin Rheumtol 2012;7:527-539
  2. Lip GY, Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 1997;34:255-65.
  3. Pyrpasopoulou A, Chatzimichailidou S, Aslanidis S. Vascular disease in systemic lupus erythematosus. Autoimmune Dis 2012;2012:876456. Gustafsson J, Gunnarsson I, Börjesson O, Pettersson S, Möller S, Fei GZ, et al. Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study. Arthritis Res Ther 2009;11:186. Khairy N, Ezzat Y, Naeem N, Taha R, Wesam R. Atherosclerosis biomarkers in female systemic lupus erythematosus patients with and without cardiovascular diseases. The Egyptian Rheumatologist 2017;39:7-12.
  4. Tyrrell PN, Beyene J, Feldman BM, McCrindle BW, Silverman ED, Bradley TJ. Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 2010;30:1014-26. Nienhuis HL, de Leeuw K, Bijzet J, van Doormaal JJ, van Roon AM, Smit AJ, et al. Small artery elasticity is decreased in patients with systemic lupus erythematosus without increased intima media thickness. Arthritis Res Ther 2010;12:181. Habe K, Wada H, Matsumoto T, Ohishi K, Ikejiri M, Tsuda K, et al. Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome. Clin Appl Thromb Hemost 2017;23:622-30.
  5. Rosato E, Molinaro I, Pisarri S, Salsano F. Digital ulcers as an initial manifestation of systemic lupus erythematosus. Intern Med 2011;50:767-9.
  6. Zardi EM, Afeltra A. Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: Are they early markers of subclinical atherosclerosis? Autoimmun Rev 2010;9:684-6.
  7. Petri M, Singh S, Tesfasyone H, Dedrick R, Fry K, Lal P, et al. Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus. Lupus 2009;18:980-9.
  8. Cen H, Leng RX, Wang W, Zhou M, Feng CC, Zhu Y, et al. Association study of IFIH1 rs1990760 polymorphism with systemic lupus erythematosus in a Chinese population. Inflammation 2013;36:444-8.
  9. Van Eyck L, De Somer L, Pombal D, Bornschein S, Frans G, Humblet-Baron S, et al. Brief Report: IFIH1 Mutation Causes Systemic Lupus Erythematosus With Selective IgA Deficiency. Arthritis Rheumatol 2015;67:1592-7.
  10. Liu Z, Davidson A. Taming lupus-a new understa